MERLIN THERAPEUTICS

Filed: July 5, 2022
research and development for the treatment or cure of the rare genetic disorder Neurofibromatosis Type 2; conducting clinical…
Owned by: Merlin Therapeutics, Inc.
Serial Number: 97488797